reference/9874224

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9874224

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	684
issn	0140-6736
issueIdentifier	9435
pageRange	675-684
publicationName	Lancet (London, England)
startingPage	675
bibliographicCitation	Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet. 2004 Aug;364(9435):675–84. doi: 10.1016/s0140-6736(04)16894-3. PMID: 15325832.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2b87e1d0293607555356df8c2b4c816 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2c10291296739a9eff272456c24e4bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53261f9f16f3d40717fbc0d8ec45dba2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b72a9089768d418225872ae7af4107fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f42acfb6cefb05094ebf9b8fd2ced437 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c3f0af75bd9e827f4ad59ac2d7faa0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e266f9833b46eb0d5764553be69c1c47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31433a1fdbbb44231771a7e8c106857d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9065acf6142f6799d5e9e9aa9fe31416 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4fb0dc78a872cef817fa525d99095cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25cae553bc512a5c2338b52bed3cf16c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_170bf3908c3801a34fb1cd1b0e65703c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5978c76207e766ae330b06c329cb60a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c1a80e1879e4d989dd7da3ba120eaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7972ce5179a1d0efd13af2210883b3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b31757c7cf2e675a2bf5ed5126ee4ac8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_930e49bbf7b1fc180f8c5c665cf74813 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab8c96b25003de1706e7f1c5bcc31c25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5763-8326
date	200408
identifier	https://pubmed.ncbi.nlm.nih.gov/15325832 https://doi.org/10.1016/s0140-6736%2804%2916894-3
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0014467 http://id.nlm.nih.gov/mesh/M0010965 http://id.nlm.nih.gov/mesh/M0025664 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001335 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0006284 http://id.nlm.nih.gov/mesh/M0450698 http://id.nlm.nih.gov/mesh/M0015401
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016861Q000009 http://id.nlm.nih.gov/mesh/D009203Q000139 http://id.nlm.nih.gov/mesh/D009288Q000009 http://id.nlm.nih.gov/mesh/D010003Q000188 http://id.nlm.nih.gov/mesh/D000894Q000009 http://id.nlm.nih.gov/mesh/D007052Q000009 http://id.nlm.nih.gov/mesh/D009930Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016861Q000627 http://id.nlm.nih.gov/mesh/D000894Q000627 http://id.nlm.nih.gov/mesh/D001241Q000009 http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009288Q000627 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D020521Q000139 http://id.nlm.nih.gov/mesh/D004008Q000031 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007052Q000627 http://id.nlm.nih.gov/mesh/D009930Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8722 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151166 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6965

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID76715547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127648365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128383506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127715174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128048219

Total number of triples: 87.